AQS.V - Aequus Pharmaceuticals Inc.

TSXV - TSXV Real Time Price. Currency in CAD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,856
2,715
2,593
1,633
Cost of Revenue
54.728
25.779
-
-
Gross Profit
1,801
2,689
-
-
Operating Expenses
Research Development
313.526
296.848
54.608
210.827
Selling General and Administrative
3,663
3,631
2,964
3,640
Total Operating Expenses
4,092
4,056
3,119
3,850
Operating Income or Loss
-2,290
-1,367
-526.104
-2,218
Interest Expense
294.912
454.84
519.593
418.669
Total Other Income/Expenses Net
41.243
-0.482
-4.197
-479.025
Income Before Tax
-2,517
-1,810
-1,045
-3,106
Income from Continuing Operations
-2,517
-1,810
-1,045
-3,106
Net Income
-2,517
-1,810
-1,045
-3,106
Net Income available to common shareholders
-2,517
-1,810
-1,045
-3,106
Basic EPS
-
-0.01
-0.01
-0.04
Diluted EPS
-
-0.01
-0.01
-0.04
Basic Average Shares
-
128,850
93,181
80,428
Diluted Average Shares
-
128,850
93,181
80,428
EBITDA
-
-1,227
-314.801
-2,378